Home  »  Industry   »  Which institution holds the most shares in GoodRx ...

Which institution holds the most shares in GoodRx Holdings Inc. (GDRX)

232 institutions hold shares in GoodRx Holdings Inc. (GDRX), with 37.22M shares held by insiders accounting for 9.49% while institutional investors hold 78.15% of the company’s shares. The shares outstanding are 397.60M, and float is at 41.09M with Short Float at 31.66%. Institutions hold 70.74% of the Float.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free.


Get the hottest stocks to trade every day before the market opens 100% free. Click here now. 

The top institutional shareholder in the company is Vanguard Group, Inc. (The) with over 3.45 million shares valued at $139.05 million. The investor’s holdings represent 5.42% of the GDRX Shares outstanding. As of Dec 30, 2020, the second largest holder is Silver Lake Group, LLC with 3.03 million shares valued at $122.24 million to account for 4.77% of the shares outstanding. The other top investors are Morgan Stanley which holds 2.7 million shares representing 4.26% and valued at over $109.11 million, while Goldman Sachs Group, Inc. holds 3.64% of the shares totaling 2.31 million with a market value of $93.24 million.

GoodRx Holdings Inc. (NASDAQ: GDRX) is -0.47% lower on its value in year-to-date trading and has touched a low of $33.39 and a high of $64.22 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The GDRX stock was last observed hovering at around $41.18 in the last trading session, with the day’s loss setting it -1.03% off its average median price target of $50.00 for the next 12 months. It is also 42.64% off the consensus price target high of $70.00 offered by 14 analysts, but current levels are -14.71% lower than the price target low of $35.00 for the same period.

Currently trading at $40.15, the stock is 2.14% and -3.11% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.76 million and changing -2.50% at the moment leaves the stock -10.85% off its SMA200. GDRX registered a loss of -19.05% in past 6-months. The firm has a 50-day simple moving average (SMA 50) of $38.78 and a 200-day simple moving average (SMA200) of $44.26.

The stock witnessed a 7.99% gain in the last 1 month and extending the period to 3 months gives it a -20.04%, and is 3.43% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 2.97% over the week and 3.73% over the month.

GoodRx Holdings Inc. (GDRX) has around 450 employees, a market worth around $15.62B and $550.70M in sales. Fwd P/E is 73.00. Profit margin for the company is -53.30%. Distance from 52-week low is 20.25% and -37.48% from its 52-week high. The company has generated returns on investments over the last 12 months (-19.30%).

GoodRx Holdings Inc. (GDRX) Analyst Forecasts

Analyst recommendations provided by FactSet shows that the consensus forecast for GoodRx Holdings Inc. (GDRX) is a “Overweight”. 14 analysts offering their recommendations for the stock have an average rating of 2.30, where 5 rate it as a Hold and 0 think it is a “Overweight”. 8 of the analysts rate the stock as a “Buy”. 1 analysts have rated the stock as a Sell or Underperform.

GoodRx Holdings Inc. is expected to release its quarterly report on 09/01/2021 and quarterly earnings per share for the current quarter are estimated at $0.07 with sales reaching $160.58M over the same period.The EPS is expected to shrink by -720.20% this year, but quarterly earnings will post 36.00% year-over-year.

GoodRx Holdings Inc. (GDRX) Insider Activity

A total of 36 insider transactions have happened at GoodRx Holdings Inc. (GDRX) in the last six months, with sales accounting for 26 and purchases happening 10 times. The most recent transaction is an insider sale by Slutsky Andrew, the company’s President, Consumer. SEC filings show that Slutsky Andrew sold 14,654 shares of the company’s common stock on Apr 26 at a price of $40.01 per share for a total of $0.59 million. Following the sale, the insider now owns 0.22 million shares.

GoodRx Holdings Inc. disclosed in a document filed with the SEC on Apr 23 that Slutsky Andrew (President, Consumer) sold a total of 10,346 shares of the company’s common stock. The trade occurred on Apr 23 and was made at $40.02 per share for $0.41 million. Following the transaction, the insider now directly holds 0.24 million shares of the GDRX stock.

Still, SEC filings show that on Apr 22, Slutsky Andrew (President, Consumer) disposed off 20,000 shares at an average price of $39.09 for $0.78 million. The insider now directly holds 3,141,523 shares of GoodRx Holdings Inc. (GDRX).

Get the hottest stocks to trade every day before the market opens 100% free. Click here now. 

Related Posts




Download Free eBook For

The 5 Best Growth Stocks 2022

100% free. stop anytime no spam